NEU

6.41%

$15.27 neuren pharmaceuticals limited

RSI at 25 backs you're theory up.

First 1834 Last

Share
Profile

Follow
slick

14,460 Posts.

7708

13/08/24

17:21

Post #: 75189409
Share

Originally posted by Esmer: ↑

Attempting to remove the psychology (and probably some so-called AI) that may have been involved in Friday's SP gyrations, and concentrating only on the fundamentals, IMO the SP now looks undervalued.

IMO, Friday's gyrations were partly caused by panic selling that resulted from holders watching how the Acadia guidance affected the pre-open match price, and then watching with horror the match price sink further during the pre-open after the Angelman results P2 were announced, particularly as the P2 results were actually positive. Possibly some did not have enough time to properly digest the P2 results, however what they could see was that the SP was taking a big hit, so took fright due to fear that something had gone horribly wrong. It might not have just been retail investors, but some instos might have also got caught up in the stampede possibly having misinterpreted the situation and possibly thinking that there was a good trading opportunity to sell and buy lower later. AI may have been to blame.

The SP turned upwards and then moved upwards very fast, soon after trading began. Only the very nimble would have grabbed the biggest bargains which were not available for very long. Although selling pressure remained throughout the day, the overall trend for the day after the initial selloff was upwards.

A similar scale of SP gyrations in other stocks usually results in a much higher volume of shares changing hands than happened for NEU on Friday, which IMO technically means that for NEU there isn't really as much selling pressure as the SP fall would indicate.So, unless some big holders now get the jitters and decide to dump, IMO on my technical chart the SP is likely to now move upwards to possible resistance at $18.50.

This is all just my humble opinion based on a mixture of technicals and fundamentals. Pharma stocks can be very volatile.

Expand

RSI at 25 backs you're theory up.

NEU Price at posting: $15.94 Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

The winners & losers on market if negative gearing were gone

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 84 more messages in this thread...

First 1834 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $15.27		Change 0.920(6.41%)		Mkt cap ! $1.951B

Open	High	Low	Value	Volume
$14.35	$15.27	$14.35	$8.720M	579.3K

Buyers (Bids)

No.	Vol.	Price($)
1	1000	$15.25

Sellers (Offers)

Price($)	Vol.	No.
$15.27	3638	4

View Market Depth

No.	Vol.	Price($)
1	650	15.200
2	1100	15.000
1	36	14.860
1	100	14.850
1	500	14.830

Price($)	Vol.	No.
15.300	1425	1
15.500	2020	2
15.700	100	1
15.800	50	1
15.900	1334	2

Last trade - 16.10pm 27/09/2024 (20 minute delay)

NEU (ASX) Chart

RSI at 25 backs you're theory up.

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

RSI at 25 backs you're theory up.

Top Stories

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The market's shrugged at China's stimulus measures all year. Why is this one different?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News